SIGA Technologies reports 2023 product sales of $131M, pre-tax operating income $84M; declares $0.60 special dividend

SIGA TECHNOLOGIES INC

Product sales increased 51% YoY to $130.7M (including supportive services) for the year ended Dec 31, 2023.
Pre-tax operating income grew 96% to $83.6M; diluted EPS of $0.95 vs $0.46 in 2022.
Board declared special cash dividend of $0.60/share, up from $0.45 last year.
Fourth-quarter product sales surged to $115.7M, driven by $98M oral TPOXX delivery to U.S. SNS.
Over 25 countries ordered oral TPOXX in past two years; EU framework yielded $18M orders in Q4.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

SIGA TECHNOLOGIES INC reported three and twelve months ended December 31, 2023 results: revenue $131 million in product revenues.

Period: three and twelve months ended December 31, 2023
Revenue: $131 million in product revenues
Result: reported results

Exact text from the filing

SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2023. “In 2023, SIGA had approximately $131 million in product revenues and approximately $84 million of pre-tax operating income,” stated Diem Nguyen, Chief Executive Officer.

View on SEC.gov

710 earnings releases filed in the last 30 days. Browse all earnings releases →

SIGA TECHNOLOGIES INC filing history →

Source: SEC EDGAR

accession 0001140361-24-012801

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.